267 related articles for article (PubMed ID: 11170262)
1. Monomethyl selenium--specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation.
Jiang C; Ganther H; Lu J
Mol Carcinog; 2000 Dec; 29(4):236-50. PubMed ID: 11170262
[TBL] [Abstract][Full Text] [Related]
2. Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lü J
Mol Cancer Ther; 2002 Oct; 1(12):1059-66. PubMed ID: 12481429
[TBL] [Abstract][Full Text] [Related]
3. Antimitogenic and proapoptotic activities of methylseleninic acid in vascular endothelial cells and associated effects on PI3K-AKT, ERK, JNK and p38 MAPK signaling.
Wang Z; Jiang C; Ganther H; Lü J
Cancer Res; 2001 Oct; 61(19):7171-8. PubMed ID: 11585751
[TBL] [Abstract][Full Text] [Related]
4. Induction of caspase-mediated apoptosis and cell-cycle G1 arrest by selenium metabolite methylselenol.
Wang Z; Jiang C; Lü J
Mol Carcinog; 2002 Jul; 34(3):113-20. PubMed ID: 12112305
[TBL] [Abstract][Full Text] [Related]
5. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake.
Jiang C; Jiang W; Ip C; Ganther H; Lu J
Mol Carcinog; 1999 Dec; 26(4):213-25. PubMed ID: 10569799
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic potential of a cancer chemopreventive flavonoid antioxidant, silymarin: inhibition of key attributes of vascular endothelial cells and angiogenic cytokine secretion by cancer epithelial cells.
Jiang C; Agarwal R; Lü J
Biochem Biophys Res Commun; 2000 Sep; 276(1):371-8. PubMed ID: 11006131
[TBL] [Abstract][Full Text] [Related]
7. PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells.
Hu H; Jiang C; Li G; Lü J
Carcinogenesis; 2005 Aug; 26(8):1374-81. PubMed ID: 15845651
[TBL] [Abstract][Full Text] [Related]
8. Methylseleninic acid inhibits PMA-stimulated pro-MMP-2 activation mediated by MT1-MMP expression and further tumor invasion through suppression of NF-kappaB activation.
Park JM; Kim A; Oh JH; Chung AS
Carcinogenesis; 2007 Apr; 28(4):837-47. PubMed ID: 17071627
[TBL] [Abstract][Full Text] [Related]
9. Flavonoids inhibit VEGF/bFGF-induced angiogenesis in vitro by inhibiting the matrix-degrading proteases.
Kim MH
J Cell Biochem; 2003 Jun; 89(3):529-38. PubMed ID: 12761886
[TBL] [Abstract][Full Text] [Related]
10. Antiangiogenic activity of selenium in cancer chemoprevention: metabolite-specific effects.
Lu J; Jiang C
Nutr Cancer; 2001; 40(1):64-73. PubMed ID: 11799926
[TBL] [Abstract][Full Text] [Related]
11. gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Basaki Y; Chikahisa L; Aoyagi K; Miyadera K; Yonekura K; Hashimoto A; Okabe S; Wierzba K; Yamada Y
Angiogenesis; 2001; 4(3):163-73. PubMed ID: 11911014
[TBL] [Abstract][Full Text] [Related]
12. Selenium compounds inhibit I kappa B kinase (IKK) and nuclear factor-kappa B (NF-kappa B) in prostate cancer cells.
Gasparian AV; Yao YJ; Lü J; Yemelyanov AY; Lyakh LA; Slaga TJ; Budunova IV
Mol Cancer Ther; 2002 Oct; 1(12):1079-87. PubMed ID: 12481431
[TBL] [Abstract][Full Text] [Related]
13. Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesis.
Adya R; Tan BK; Punn A; Chen J; Randeva HS
Cardiovasc Res; 2008 May; 78(2):356-65. PubMed ID: 18093986
[TBL] [Abstract][Full Text] [Related]
14. SI-27, a novel inhibitor of matrix metalloproteinases with antiangiogenic activity: detection with a variable-pressure scanning electron microscope.
Yoshida D; Noha M; Watanabe K; Sugisaki Y; Teramoto A
Neurosurgery; 2002 Mar; 50(3):578-86; discussion 586-8. PubMed ID: 11841727
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.
Wang H; Keiser JA
Circ Res; 1998 Oct; 83(8):832-40. PubMed ID: 9776730
[TBL] [Abstract][Full Text] [Related]
16. The protein tyrosine kinase inhibitor SU5614 inhibits VEGF-induced endothelial cell sprouting and induces growth arrest and apoptosis by inhibition of c-kit in AML cells.
Spiekermann K; Faber F; Voswinckel R; Hiddemann W
Exp Hematol; 2002 Jul; 30(7):767-73. PubMed ID: 12135675
[TBL] [Abstract][Full Text] [Related]
17. Interaction with endothelial cells is a prerequisite for branching ductal-alveolar morphogenesis and hyperplasia of preneoplastic human breast epithelial cells: regulation by estrogen.
Shekhar MP; Werdell J; Tait L
Cancer Res; 2000 Jan; 60(2):439-49. PubMed ID: 10667599
[TBL] [Abstract][Full Text] [Related]
18. Green tea inhibits vascular endothelial growth factor (VEGF) induction in human breast cancer cells.
Sartippour MR; Shao ZM; Heber D; Beatty P; Zhang L; Liu C; Ellis L; Liu W; Go VL; Brooks MN
J Nutr; 2002 Aug; 132(8):2307-11. PubMed ID: 12163680
[TBL] [Abstract][Full Text] [Related]
19. Hepatocyte growth factor/scatter factor can induce angiogenesis independently of vascular endothelial growth factor.
Sengupta S; Gherardi E; Sellers LA; Wood JM; Sasisekharan R; Fan TP
Arterioscler Thromb Vasc Biol; 2003 Jan; 23(1):69-75. PubMed ID: 12524227
[TBL] [Abstract][Full Text] [Related]
20. Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density.
Wang Z; Hu H; Li G; Lee HJ; Jiang C; Kim SH; Lü J
Int J Cancer; 2008 Jan; 122(1):15-24. PubMed ID: 17847021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
